Murine models of hepatitis C: What can we look forward to?

Antiviral Research

Volumn 104, Issue 1, 2014, Pages 15-22

  Von Schaewen, Markus ^a   Ploss, Alexander ^a  

^a PRINCETON UNIVERSITY   (United States)

Author keywords

Animal models; Anti viral immunity; Drug development; Hepatitis C; Species tropism; Vaccines

Indexed keywords

DISEASE MODEL; HEPATITIS C; HUMAN; IMMUNE RESPONSE; IMMUNITY; MOUSE; MOUSE MODEL; MURINE MODEL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ANIMAL MODELS; ANTI-VIRAL IMMUNITY; DRUG DEVELOPMENT; HEPATITIS C; SPECIES TROPISM; VACCINES;

ANIMALS; DISEASE MODELS, ANIMAL; HEPACIVIRUS; HEPATITIS C; HUMANS; MICE;

EID: 84894128830     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2014.01.007     Document Type: Note

References (90)

1. National institutes of health consensus development conference statement: management of hepatitis C 2002 (June 10-12, 2002) Gastroenterology 123 2002 2082 2099
2. V. Agnello, G. Abel, M. Elfahal, G.B. Knight, and Q.-X. Zhang Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor Proc. Natl. Acad. Sci. U.S.A. 96 1999 12766 12771 (Pubitemid 29513577)
3. Anggakusuma, C.C. Colpitts, L.M. Schang, H. Rachmawati, A. Frentzen, S. Pfaender, P. Behrendt, R.J. Brown, D. Bankwitz, J. Steinmann, M. Ott, P. Meuleman, C.M. Rice, A. Ploss, T. Pietschmann, and E. Steinmann Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells Gut 2013
4. H. Barth, C. Schafer, M.I. Adah, F. Zhang, R.J. Linhardt, H. Toyoda, A. Kinoshita-Toyoda, T. Toida, T.H. Van Kuppevelt, E. Depla, F. Von Weizsacker, H.E. Blum, and T.F. Baumert Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate J. Biol. Chem. 278 2003 41003 41012 (Pubitemid 37280923)
5. E. Billerbeck, Y. de Jong, M. Dorner, C. de la Fuente, and A. Ploss Animal models for hepatitis C Curr. Top. Microbiol. Immunol. 369 2013 49 86
6. K.D. Bissig, S.F. Wieland, P. Tran, M. Isogawa, T.T. Le, F.V. Chisari, and I.M. Verma Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment J. Clin. Invest. 120 2010 924 930
7. J. Bitzegeio, D. Bankwitz, K. Hueging, S. Haid, C. Brohm, M.B. Zeisel, E. Herrmann, M. Iken, M. Ott, T.F. Baumert, and T. Pietschmann Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors PLoS Pathog. 6 2010 e1000978
8. J. Bukh, C.L. Apgar, S. Govindarajan, and R.H. Purcell Host range studies of GB virus-B hepatitis agent, the closest relative of hepatitis C virus, in New World monkeys and chimpanzees J. Med. Virol. 65 2001 694 697 (Pubitemid 33135097)
9. P.D. Burbelo, E.J. Dubovi, P. Simmonds, J.L. Medina, J.A. Henriquez, N. Mishra, J. Wagner, R. Tokarz, J.M. Cullen, M.J. Iadarola, C.M. Rice, W.I. Lipkin, and A. Kapoor Serology-enabled discovery of genetically diverse hepaciviruses in a new host J. Virol. 86 2012 6171 6178
10. J. Chang, E. Nicolas, D. Marks, C. Sander, A. Lerro, M.A. Buendia, C. Xu, W.S. Mason, T. Moloshok, R. Bort, K.S. Zaret, and J.M. Taylor MiR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1 RNA Biol. 1 2004 106 113
11. K.S. Chang, Z. Cai, C. Zhang, G.C. Sen, B.R. Williams, and G. Luo Replication of hepatitis C virus (HCV) RNA in mouse embryonic fibroblasts: protein kinase R (PKR)-dependent and PKR-independent mechanisms for controlling HCV RNA replication and mediating interferon activities J. Virol. 80 2006 7364 7374 (Pubitemid 44092559)
12. A.A. Chen, D.K. Thomas, L.L. Ong, R.E. Schwartz, T.R. Golub, and S.N. Bhatia Humanized mice with ectopic artificial liver tissues Proc. Natl. Acad. Sci. U. S. A. 108 2011 11842 118427
13. B.K. Chou, Z. Ye, and L. Cheng Generation and homing of iPSC-derived hematopoietic cells in vivo Mol. Ther. 21 2013 1292 1293
14. K.D. Conrad, and M. Niepmann The role of microRNAs in hepatitis C virus RNA replication Arch. Virol. 2013
15. Y.P. de Jong, C.M. Rice, and A. Ploss New horizons for studying human hepatotropic infections J. Clin. Invest. 120 2010 650 653
16. M. Dorner, J.A. Horwitz, J.B. Robbins, W.T. Barry, Q. Feng, K. Mu, C.T. Jones, J.W. Schoggins, M.T. Catanese, D.R. Burton, M. Law, C.M. Rice, and A. Ploss A genetically humanized mouse model for hepatitis C virus infection Nature 474 2011 208 211
17. M. Dorner, J.A. Horwitz, B.M. Donovan, R.N. Labitt, W.C. Budell, T. Friling, A. Vogt, M.T. Catanese, T. Satoh, T. Kawai, S. Akira, M. Law, C.M. Rice, and A. Ploss Completion of the entire hepatitis C virus life cycle in genetically humanized mice Nature 501 2013 237 241
18. B.R. Edlin Perspective: test and treat this silent killer Nature 474 2011 S18 S19
19. M.J. Evans, T. von Hahn, D.M. Tscherne, A.J. Syder, M. Panis, B. Wolk, T. Hatziioannou, J.A. McKeating, P.D. Bieniasz, and C.M. Rice Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry Nature 446 2007 801 805 (Pubitemid 46582027)
20. S.M. Feinstone, D.J. Hu, and M.E. Major Prospects for prophylactic and therapeutic vaccines against hepatitis C virus Clin. Infect. Dis. 55 Suppl 1 2012 S25 S32
21. L. Feldmeyer, M. Huber, F. Fellmann, J.S. Beckmann, E. Frenk, and D. Hohl Confirmation of the origin of NISCH syndrome Hum. Mutat. 27 2006 408 410 (Pubitemid 43673326)
22. A. Frentzen, K. Huging, J. Bitzegeio, M. Friesland, S. Haid, J. Gentzsch, M. Hoffmann, D. Lindemann, G. Zimmer, F. Zielecki, F. Weber, E. Steinmann, and T. Pietschmann Completion of hepatitis C virus replication cycle in heterokaryons excludes dominant restrictions in human non-liver and mouse liver cell lines PLoS Pathog. 7 2011 e1002029
23. A. Frentzen, Gurlevik.E. Anggakusuma, K. Hueging, S. Knocke, C. Ginkel, R.J. Brown, M. Heim, M.T. Dill, A. Kroger, U. Kalinke, L. Kaderali, F. Kuehnel, and T. Pietschmann Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver-derived cells Hepatology 59 2014 78 88
24. D. Ge, J. Fellay, A.J. Thompson, J.S. Simon, K.V. Shianna, T.J. Urban, E.L. Heinzen, P. Qiu, A.H. Bertelsen, A.J. Muir, M. Sulkowski, J.G. McHutchison, and D.B. Goldstein Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature 461 2009 399 401
25. E. Giang, M. Dorner, J.C. Prentoe, M. Dreux, M.J. Evans, J. Bukh, C.M. Rice, A. Ploss, D.R. Burton, and M. Law Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus Proc. Natl. Acad. Sci. U.S.A. 109 2012 6205 6210
26. S. Hadj-Rabia, L. Baala, P. Vabres, D. Hamel-Teillac, E. Jacquemin, M. Fabre, S. Lyonnet, Y. De Prost, A. Munnich, M. Hadchouel, and A. Smahi Claudin-1 gene mutations in neonatal sclerosing cholangitis associated with ichthyosis: a tight junction disease Gastroenterology 127 2004 1386 1390 (Pubitemid 39457765)
27. D. Haridass, Q. Yuan, P.D. Becker, T. Cantz, M. Iken, M. Rothe, N. Narain, M. Bock, M. Norder, N. Legrand, H. Wedemeyer, K. Weijer, H. Spits, M.P. Manns, J. Cai, H. Deng, J.P. Di Santo, C.A. Guzman, and M. Ott Repopulation efficiencies of adult hepatocytes, fetal liver progenitor cells, and embryonic stem cell-derived hepatic cells in albumin-promoter-enhancer urokinase-type plasminogen activator mice Am. J. Pathol. 175 2009 1483 1492
28. D. Hockemeyer, H. Wang, S. Kiani, C.S. Lai, Q. Gao, J.P. Cassady, G.J. Cost, L. Zhang, Y. Santiago, J.C. Miller, B. Zeitler, J.M. Cherone, X. Meng, S.J. Hinkley, E.J. Rebar, P.D. Gregory, F.D. Urnov, and R. Jaenisch Genetic engineering of human pluripotent cells using TALE nucleases Nat. Biotechnol. 29 2011 731 734
29. T.L. Innerarity, K.H. Weisgraber, K.S. Arnold, R.W. Mahley, R.M. Krauss, G.L. Vega, and S.M. Grundy Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding Proc. Natl. Acad. Sci. U.S.A. 84 1987 6919 6923 (Pubitemid 18025501)
30. A.B. Jesudian, Y.P. de Jong, and I.M. Jacobson Emerging therapeutic targets for hepatitis C virus infection Clin. Gastroenterol. Hepatol. 11 612-619 2013 e611
31. A. Kapoor, P. Simmonds, G. Gerold, N. Qaisar, K. Jain, J.A. Henriquez, C. Firth, D.L. Hirschberg, C.M. Rice, S. Shields, and W.I. Lipkin Characterization of a canine homolog of hepatitis C virus Proc. Natl. Acad. Sci. U.S.A. 108 2011 11608 11613
32. A. Kapoor, P. Simmonds, T.K. Scheel, B. Hjelle, J.M. Cullen, P.D. Burbelo, L.V. Chauhan, R. Duraisamy, M. Sanchez Leon, K. Jain, K.J. Vandegrift, C.H. Calisher, C.M. Rice, and W.I Lipkin Identification of rodent homologs of hepatitis C virus and pegiviruses mBio 4 2013 (e00216-e00213)
33. P. Karayiannis, L.M. Petrovic, M. Fry, D. Moore, M. Enticott, M.J. McGarvey, P.J. Scheuer, and H.C. Thomas Studies of GB hepatitis agent in tamarins Hepatology 9 1989 186 192 (Pubitemid 19063299)
34. K. Kosaka, N. Hiraga, M. Imamura, S. Yoshimi, E. Murakami, T. Nakahara, Y. Honda, A. Ono, T. Kawaoka, M. Tsuge, H. Abe, C.N. Hayes, D. Miki, H. Aikata, H. Ochi, Y. Ishida, C. Tateno, K. Yoshizato, T. Sasaki, and K. Chayama A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections Biochem. Biophys. Res. Commun. 441 2013 230 235
35. G. Koutsoudakis, A. Kaul, E. Steinmann, S. Kallis, V. Lohmann, T. Pietschmann, and R. Bartenschlager Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses J. Virol. 80 2006 5308 5320
36. D. Lamarre, P.C. Anderson, M. Bailey, P. Beaulieu, G. Bolger, P. Bonneau, M. Bos, D.R. Cameron, M. Cartier, M.G. Cordingley, A.M. Faucher, N. Goudreau, S.H. Kawai, G. Kukolj, L. Lagace, S.R. LaPlante, H. Narjes, M.A. Poupart, J. Rancourt, R.E. Sentjens, R. St George, B. Simoneau, G. Steinmann, D. Thibeault, Y.S. Tsantrizos, S.M. Weldon, C.L. Yong, and M. Llinas-Brunet An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus Nature 426 2003 186 189 (Pubitemid 37442587)
37. R.E. Lanford, D. Chavez, L. Notvall, and K.M. Brasky Comparison of tamarins and marmosets as hosts for GBV-B infections and the effect of immunosuppression on duration of viremia Virology 311 2003 72 80 (Pubitemid 36794211)
38. R.E. Lanford, E.S. Hildebrandt-Eriksen, A. Petri, R. Persson, M. Lindow, M.E. Munk, S. Kauppinen, and H. Orum Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection Science 327 2010 198 201
39. L.T. Lin, R.S. Noyce, T.N. Pham, J.A. Wilson, G.R. Sisson, T.I. Michalak, K.L. Mossman, and C.D. Richardson Replication of subgenomic hepatitis C virus replicons in mouse fibroblasts is facilitated by deletion of interferon regulatory factor 3 and expression of liver-specific microRNA 122 J. Virol. 84 2010 9170 9180
40. S. Liu, W. Yang, L. Shen, J.R. Turner, C.B. Coyne, and T. Wang Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection J. Virol. 83 2009 2011 2014
41. G. Long, M.S. Hiet, M.P. Windisch, J.Y. Lee, V. Lohmann, and R. Bartenschlager Mouse hepatic cells support assembly of infectious hepatitis C virus particles Gastroenterology 141 2011 1057 1066
42. J. Lupberger, M.B. Zeisel, F. Xiao, C. Thumann, I. Fofana, L. Zona, C. Davis, C.J. Mee, M. Turek, S. Gorke, C. Royer, B. Fischer, M.N. Zahid, D. Lavillette, J. Fresquet, F.L. Cosset, S.M. Rothenberg, T. Pietschmann, A.H. Patel, P. Pessaux, M. Doffoel, W. Raffelsberger, O. Poch, J.A. McKeating, L. Brino, and T.F. Baumert EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy Nat. Med. 17 2011 589 595
43. R.W. Mahley Apolipoprotein E: cholesterol transport protein with expanding role in cell biology Science 240 1988 622 630
44. D.N. Martin, and S.L. Uprichard Identification of transferrin receptor 1 as a hepatitis C virus entry factor Proc. Natl. Acad. Sci. U.S.A. 110 2013 10777 10782
45. D.F. Mercer, D.E. Schiller, J.F. Elliott, D.N. Douglas, C. Hao, A. Rinfret, W.R. Addison, K.P. Fischer, T.A. Churchill, J.R. Lakey, D.L. Tyrrell, and N.M. Kneteman Hepatitis C virus replication in mice with chimeric human livers Nat. Med. 7 2001 927 933 (Pubitemid 32756430)
46. J. Mestas, and C.C. Hughes Of mice and not men: differences between mouse and human immunology J. Immunol. 172 2004 2731 2738 (Pubitemid 38263654)
47. P. Meuleman, and G. Leroux-Roels The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV Antiviral Res. 80 2008 231 238
48. P. Meuleman, L. Libbrecht, R. De Vos, B. de Hemptinne, K. Gevaert, J. Vandekerckhove, T. Roskams, and G. Leroux-Roels Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera Hepatology 41 2005 847 856 (Pubitemid 40462948)
49. S. Molina, V. Castet, C. Fournier-Wirth, L. Pichard-Garcia, R. Avner, D. Harats, J. Roitelman, R. Barbaras, P. Graber, P. Ghersa, M. Smolarsky, A. Funaro, F. Malavasi, D. Larrey, J. Coste, J.M. Fabre, A. Sa-Cunha, and P. Maurel The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus J. Hepatol. 46 2007 411 419 (Pubitemid 46201721)
50. M. Monazahian, I. Bohme, S. Bonk, A. Koch, C. Scholz, S. Grethe, and R. Thomssen Low density lipoprotein receptor as a candidate receptor for hepatitis C virus J. Med. Virol. 57 1999 223 229 (Pubitemid 29069727)
51. R. Nandakumar, K. Finsterbusch, C. Lipps, B. Neumann, M. Grashoff, S. Nair, I. Hochnadel, S. Lienenklaus, I. Wappler, E. Steinmann, H. Hauser, T. Pietschmann, and A. Kroger Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms Gastroenterology 145 1414-1423 2013 e1411
52. D.B. Olsen, M.E. Davies, L. Handt, K. Koeplinger, N.R. Zhang, S.W. Ludmerer, D. Graham, N. Liverton, M. MacCoss, D. Hazuda, and S.S. Carroll Sustained viral response in a hepatitis C virus-infected chimpanzee via a combination of direct-acting antiviral agents Antimicrob. Agents Chemother. 55 2011 937 939
53. D.M. Owen, H. Huang, J. Ye, and M. Gale Jr. Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor Virology 394 2009 99 108
54. P. Pileri, Y. Uematsu, S. Campagnoli, G. Galli, F. Falugi, R. Petracca, A.J. Weiner, M. Houghton, D. Rosa, G. Grandi, and S. Abrignani Binding of hepatitis C virus to CD81 Science 282 1998 938 941 (Pubitemid 28507525)
55. A. Ploss, M.J. Evans, V.A. Gaysinskaya, M. Panis, H. You, Y.P. de Jong, and C.M. Rice Human occludin is a hepatitis C virus entry factor required for infection of mouse cells Nature 457 2009 882 886
56. L. Prokunina-Olsson, B. Muchmore, W. Tang, R.M. Pfeiffer, H. Park, H. Dickensheets, D. Hergott, P. Porter-Gill, A. Mumy, I. Kohaar, S. Chen, N. Brand, M. Tarway, L. Liu, F. Sheikh, J. Astemborski, H.L. Bonkovsky, B.R. Edlin, C.D. Howell, T.R. Morgan, D.L. Thomas, B. Rehermann, R.P. Donnelly, and T.R. O'Brien A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus Nat. Genet. 45 2013 164 171
57. P. Roelandt, S. Obeid, J. Paeshuyse, J. Vanhove, A. Van Lommel, Y. Nahmias, F. Nevens, J. Neyts, and C.M. Verfaillie Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus J. Hepatol. 57 2012 246 251
58. S. Romeo, J. Kozlitina, C. Xing, A. Pertsemlidis, D. Cox, L.A. Pennacchio, E. Boerwinkle, J.C. Cohen, and H.H. Hobbs Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Nat. Genet. 40 2008 1461 1465
59. A. Rongvaux, H. Takizawa, T. Strowig, T. Willinger, E.E. Eynon, R.A. Flavell, and M.G. Manz Human hemato-lymphoid system mice: current use and future potential for medicine Annu. Rev. Immunol. 31 2013 635 674
60. B. Sainz Jr., N. Barretto, D.N. Martin, N. Hiraga, M. Imamura, S. Hussain, K.A. Marsh, X. Yu, K. Chayama, W.A. Alrefai, and S.L. Uprichard Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor Nat. Med. 18 2012 281 285
61. L. Sandmann, and A. Ploss Barriers of hepatitis C virus interspecies transmission Virology 435 2013 70 80
62. E. Scarselli, H. Ansuini, R. Cerino, R.M. Roccasecca, S. Acali, G. Filocamo, C. Traboni, A. Nicosia, R. Cortese, and A. Vitelli The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus EMBO J. 21 2002 5017 5025
63. G.G. Schaluder, G.J. Dawson, J.N. Simons, T.J. Pilot-Matias, R.A. Gutierrez, C.A. Heynen, M.F. Knigge, G.S. Kurpiewski, S.L. Buijk, and T.P. Leary et al. Molecular and serologic analysis in the transmission of the GB hepatitis agents J. Med. Virol. 46 1995 81 90
64. R.E. Schwartz, K. Trehan, L. Andrus, T.P. Sheahan, A. Ploss, S.A. Duncan, C.M. Rice, and S.N. Bhatia Modeling hepatitis C virus infection using human induced pluripotent stem cells Proc. Natl. Acad. Sci. U.S.A. 109 2012 2544 2548
65. J. Shan, R.E. Schwartz, N.T. Ross, D.J. Logan, D. Thomas, S.A. Duncan, T.E. North, W. Goessling, A.E. Carpenter, and S.N. Bhatia Identification of small molecules for human hepatocyte expansion and iPS differentiation Nat. Chem. Biol. 9 2013 514 520
66. T. Sheahan, C.T. Jones, and A. Ploss Advances and challenges in studying hepatitis C virus in its native environment Expert Rev. Gastroenterol. Hepatol. 4 2010 541 550
67. J.N. Simons, T.P. Leary, G.J. Dawson, T.J. Pilot-Matias, A.S. Muerhoff, G.G. Schlauder, S.M. Desai, and I.K. Mushahwar Isolation of novel virus-like sequences associated with human hepatitis Nat. Med. 1 1995 564 569
68. K. Si-Tayeb, F.K. Noto, M. Nagaoka, J. Li, M.A. Battle, C. Duris, P.E. North, S. Dalton, and S.A. Duncan Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells Hepatology 51 2010 297 305
69. M. Sourisseau, O. Goldman, W. He, J.L. Gori, H.P. Kiem, V. Gouon-Evans, and M.J. Evans Hepatic cells derived from induced pluripotent stem cells of pigtail macaques support hepatitis C virus infection Gastroenterology 145 966-969 2013 e967
70. K.R. Stevens, M.D. Ungrin, R.E. Schwartz, S. Ng, B. Carvalho, K.S. Christine, R.R. Chaturvedi, C.Y. Li, P.W. Zandstra, C.S. Chen, and S.N. Bhatia InVERT molding for scalable control of tissue microarchitecture Nat. Commun. 4 2013 1847
71. V. Suppiah, M. Moldovan, G. Ahlenstiel, T. Berg, M. Weltman, M.L. Abate, M. Bassendine, U. Spengler, G.J. Dore, E. Powell, S. Riordan, D. Sheridan, A. Smedile, V. Fragomeli, T. Muller, M. Bahlo, G.J. Stewart, D.R. Booth, and J. George IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy Nat. Genet. 41 2009 1100 1104
72. K. Takahashi, and S. Yamanaka Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 2006 663 676 (Pubitemid 44233629)
73. K. Takahashi, K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, K. Tomoda, and S. Yamanaka Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 2007 861 872 (Pubitemid 350138099)
74. Y. Tanaka, N. Nishida, M. Sugiyama, M. Kurosaki, K. Matsuura, N. Sakamoto, M. Nakagawa, M. Korenaga, K. Hino, S. Hige, Y. Ito, E. Mita, E. Tanaka, S. Mochida, Y. Murawaki, M. Honda, A. Sakai, Y. Hiasa, S. Nishiguchi, A. Koike, I. Sakaida, M. Imamura, K. Ito, K. Yano, N. Masaki, F. Sugauchi, N. Izumi, K. Tokunaga, and M. Mizokami Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C Nat. Genet. 41 2009 1105 1109
75. A. Tesfaye, J. Stift, D. Maric, Q. Cui, H.P. Dienes, and S.M. Feinstone Chimeric mouse model for the infection of hepatitis B and C viruses PLoS One 8 2013 e77298
76. D.L. Thomas, C.L. Thio, M.P. Martin, Y. Qi, D. Ge, C. O'Huigin, J. Kidd, K. Kidd, S.I. Khakoo, G. Alexander, J.J. Goedert, G.D. Kirk, S.M. Donfield, H.R. Rosen, L.H. Tobler, M.P. Busch, J.G. McHutchison, D.B. Goldstein, and M. Carrington Genetic variation in IL28B and spontaneous clearance of hepatitis C virus Nature 461 2009 798 801
77. X. Tong, and L. Yin Circadian rhythms in liver physiology and liver diseases Compr. Physiol. 3 2013 917 940
78. C. Torre, C. Perret, and S. Colnot Molecular determinants of liver zonation Prog. Mol. Biol. Transl. Sci. 97 2010 127 150
79. T. Touboul, N.R. Hannan, S. Corbineau, A. Martinez, C. Martinet, S. Branchereau, S. Mainot, H. Strick-Marchand, R. Pedersen, J. Di Santo, A. Weber, and L. Vallier Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development Hepatology 51 2010 1754 1765
80. S.L. Uprichard, J. Chung, F.V. Chisari, and T. Wakita Replication of a hepatitis C virus replicon clone in mouse cells Virol. J. 3 2006 89
81. M.C. van Zelm, J. Smet, B. Adams, F. Mascart, L. Schandene, F. Janssen, A. Ferster, C.C. Kuo, S. Levy, J.J. van Dongen, and M. van der Burg CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency J. Clin. Invest. 120 2010 1265 1274
82. T. Vanwolleghem, P. Meuleman, L. Libbrecht, T. Roskams, R. De Vos, and G. Leroux-Roels Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouse Gastroenterology 133 2007 1144 1155 (Pubitemid 47494454)
83. M. Vergeer, S.J. Korporaal, R. Franssen, I. Meurs, R. Out, G.K. Hovingh, M. Hoekstra, J.A. Sierts, G.M. Dallinga-Thie, M.M. Motazacker, A.G. Holleboom, T.J. Van Berkel, J.J. Kastelein, M. Van Eck, and J.A. Kuivenhoven Genetic variant of the scavenger receptor BI in humans N. Engl. J. Med. 364 2011 136 145
84. A. Vogt, M.A. Scull, T. Friling, J.A. Horwitz, B.M. Donovan, M. Dorner, G. Gerold, R.N. Labitt, C.M. Rice, and A. Ploss Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines Virology 444 2013 1 11
85. M.L. Washburn, M.T. Bility, L. Zhang, G.I. Kovalev, A. Buntzman, J.A. Frelinger, W. Barry, A. Ploss, C.M. Rice, and L. Su A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease Gastroenterology 140 2011 1334 1344
86. X. Wu, J.M. Robotham, E. Lee, S. Dalton, N.M. Kneteman, D.M. Gilbert, and H. Tang Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation PLoS pathog. 8 2012 e1002617
87. M.B. Zeisel, D.J. Felmlee, and T.F. Baumert Hepatitis C virus entry Curr. Top. Microbiol. Immunol. 369 2013 87 112
88. Z. Zhang Genomic landscape of liver cancer Nat.Genet. 44 2012 1075 1077
89. S.Y. Zhang, S. Boisson-Dupuis, A. Chapgier, K. Yang, J. Bustamante, A. Puel, C. Picard, L. Abel, E. Jouanguy, and J.L. Casanova Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense Immunol. Rev. 226 2008 29 40
90. Q. Zhu, J.T. Guo, and C. Seeger Replication of hepatitis C virus subgenomes in nonhepatic epithelial and mouse hepatoma cells J. Virol. 77 2003 9204 9210 (Pubitemid 37011017)